We serve Chemical Name:ethyl 2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrole-5-carboxylate CAS:132414-79-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:ethyl 2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrole-5-carboxylate
CAS.NO:132414-79-0
Synonyms:ethyl 2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrole-5-carboxylate
Molecular Formula:C9H14N2O2
Molecular Weight:182.22000
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:277ºC at 760 mmHg
Density:1.122g/cm3
Index of Refraction:1.499
PSA:41.57000
Exact Mass:182.10600
LogP:0.97260
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like ethyl 2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrole-5-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrole-5-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrole-5-carboxylate Use and application,ethyl 2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrole-5-carboxylate technical grade,usp/ep/jp grade.
Related News: Specifically, the EC has cleared Verquvo (vericiguat) to treat patients who are stabilised after a recent decompensation event requiring intravenous therapy. calcium 2-(carboxylatomethoxy)propane-1,2,3-tricarboxylate manufacturers SAN FRANCISCO–(BUSINESS WIRE)–BetterUp, the inventor of virtual coaching and the first to democratize professional coaching across the entire enterprise, announced today that it is putting down roots in Europe with two new offices in Munich and London. rel-(1R,2R)-2-((benzyloxy)methyl)-N,N-dimethylcyclopropan-1-amine hydrochloride suppliers AstraZeneca’s application for anifrolumab in SLE is under review by regulatory authorities in the US, EU and Japan, with decisions anticipated in the second half of 2021. Anifrolumab is not currently approved in any country. Behenaldehyd-(2.4-dinitro-phenylhydrazon) vendor & factory.